Cargando…
A case of subretinal neovascularization treated with intravitreal ranibizumab in a patient with idiopathic juxtafoveal retinal telangiectasis
A 65-year-old lady presented with decreased vision in her left eye (LE). Best corrected visual acuity (BCVA) was 1/20. Complete examination showed idiopathic juxtafoveal retinal telangiectasis associated with subretinal neovascularization and she was treated with intravitreal ranibizumab every month...
Autores principales: | Karagiannis, Dimitrios, Georgalas, Ilias, Ladas, Ioannis, Eustratios, Parikakis, Mitropoulos, Panagiotis |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2685226/ https://www.ncbi.nlm.nih.gov/pubmed/19503767 |
Ejemplares similares
-
Clinical Features of Idiopathic Juxtafoveal Telangiectasis in Koreans
por: Lee, Seung Woo, et al.
Publicado: (2011) -
Location of submacular hemorrhage as a predictor of visual outcome after intravitreal ranibizumab for age-related macular degeneration
por: Karagiannis, Dimitrios, et al.
Publicado: (2017) -
Treatment of myopic choroidal neovascularization with intravitreal ranibizumab injections: the role of age
por: Karagiannis, Dimitrios, et al.
Publicado: (2017) -
Changing from bevacizumab to ranibizumab in age-related macular degeneration. Is it safe?
por: Karagiannis, Dimitrios A, et al.
Publicado: (2009) -
Severe hypotony and filtering bleb leak after intravitreal injection of ranibizumab
por: Georgalas, Ilias, et al.
Publicado: (2009)